Connect with us

Technology

OXMAN Unveils the O° Shoe – a 100% Biodegradable Shoe made without Petrochemicals, producing Zero Microplastics

Published

on

The O° collection is made using patent pending OXMAN technology that integrates digital, material, biological, and robotic innovations and uses a single organic material to create 100% biobased consumer products

WATCH VIDEO

NEW YORK, Oct. 31, 2024 /PRNewswire/ — OXMAN, a design lab whose mission is to create and deliver nature-centric products and environments to its clients and the natural world, has unveiled O°, a biomaterial, digital, and robotic technology platform that powers the production of biobased textiles and wearables that are 100% biodegradable when disposed of, made entirely with organic material and without petrochemicals or glues, and producing no microplastics. O° (pronounced “O-Zero”) removes the complexity inherent in conventional fabrication processes, enabling the creation of consumer products from one material, under one roof, with minimal human intervention — through a nearly zero-waste process. The first product to be created using O° platform is a collection of shoes made entirely of polyhydroxyalkanoates (PHAs), a class of organic material known for its versatility and biodegradability. 

 

“PHAs have long been recognized as a promising alternative to petroleum-based plastics,” noted Neri Oxman, CEO and Founder of OXMAN. “We have successfully elevated the potential of PHA through the development of O°, a new technology for the design and fabrication of products that seeks to minimize harm in its conception and nourish the environment in its afterlife. We are thrilled to unveil our first product using this new technology: the O° shoe, which is made using 100% PHA, is 100% biodegradable, and has no petrochemicals or microplastics.”

0% petrochemicals, 0% forever chemicals, 0% microplastics, and 100% biodegradable
PHAs can be produced by bacteria which consume atmospheric carbon dioxide, methane, and/or food waste, reducing carbon in the environment as they grow. They are biologically recyclable, and 100% biodegradable in ambient conditions. As a result, O° textiles and shoes do not leave behind microplastics when they decompose. O° textiles and shoes are made entirely of PHAs, so when they decompose they become one with the environment, returning to the bacteria from which they originated. However, just like traditional biodegradable materials used for apparel such as cotton, wool, and silk, PHA will not biodegrade while being worn, washed, or stored.

A high-efficiency design process
O° shoes embody the versatility of PHAs by incorporating precise designs informed by the kinetics of human motion. Whether they take final form as a walking or running shoe, or ballet slipper, each shoe has a base layer of a knitted upper and outer layers that are printed on the textile to provide specific functionality including reinforcement, cushioning, strength, and pliability. The versatility and automation built into the O° platform enable rapid iterations and  an accelerated development process from design to production.

A near zero-waste production process
A compact robotic system is central to the O° platform: the O° robotic system 3D prints custom PHA blends onto a textile that is 3D knitted on an industrial flatbed machine from a 100% PHA yarn produced through a process of extrusion and melt spinning. By using this knitting and printing technology to create shape and movement, OXMAN has eliminated the cut-and-sew and adhesion processes associated with traditional shoe assembly. The O° technology offers a near zero-waste production process and requires minimal human involvement and intervention, enabling local, low-cost production, minimizing the transport cost and environmental impact of the distant supply chains typical of the shoe industry.

Bio-engineered colorways, free of petrochemicals
Many industrial pigments and dyes are sourced from raw materials derived from petro-chemicals which release environmentally damaging chemicals during their production and usage. These dyes and pigments are dependent on a resource-intensive and complex global supply chain for synthesis, processing, and transport. In contrast, bacteria can produce pigments from simple and abundant natural resources. O° uses bacteria not just as a source of material, but also to encode other functional properties such as pigment production to simplify and centralize the manufacturing process.

OXMAN’s O° platform builds on the promise of PHAs by tuning the fabrication process and offering an alternative design and production process that holistically considers a product’s entire lifecycle, from conception to decomposition. 

OXMAN is now initiating discussions with potential partners, investors, and brand collaborators to bring the production of O° shoes and textiles to scale and to market.  We look forward to hearing from you. You can reach us here.

About OXMAN
OXMAN is a design lab whose mission is to create and deliver nature-centric products and environments to its clients and the natural world. Bringing together computational design, robotics, materials science, green chemistry, biology, and eco-system engineering, OXMAN’s work reinvents the industrial systems that dictate how we design and produce everyday things—from the foods we eat and the clothes we wear to the buildings we inhabit. https://oxman.com

O° CONTACT
https://oxman.com/contact

MEDIA CONTACT
Alex Klimoski
oxman@resnicow.com
+1 (212) 671-5184 

BACKGROUND
The Problem: Endless Assemblies, Forever Chemicals
The footwear design and manufacturing industry faces significant environmental challenges that include hazardous chemical formulations polluting our air, water and soil, greenhouse gas emissions, human exploitation, lack of supply chain traceability, as well as lack of sustainable end-of-life scenarios for materials that cannot be recycled or biodegraded.

Facts & Figures:

24+ billion shoes are manufactured worldwide each year1,2,3300+ million pairs of shoes are discarded annually, 95% of which wind up in landfill2,3Shoes do not break down easily or quickly: shock-absorbent soles can remain in a landfill for 1,000 years4On average, 40 distinct materials are used to create a traditional shoe (e.g., foams, fabrics, rubbers, coatings, adhesives)5″Forever chemicals” are found in almost all mass-produced shoes today (33-4200 parts per billion can be found in a traditional shoe)6Shoes made from petroleum-derived plastics account for 1.4% of global greenhouse emissions7,8

The Solution: One Material, One System
O° is a design platform that starts and ends with biology. It embodies an automated, vertically integrated, bio-digital fabrication system for lifecycle design of multi-functional mono-material products. 

Made entirely of polyhydroxyalkanoates (PHAs), a bacterially-produced thermo-plastic polymer, the mono-material O° enables the design and digital fabrication of apparel items, such as shoes and textiles, that exhibit a range of physical properties, functions, and end-of-life trajectories. By cultivating our materials from bacteria—as opposed to extracting them from resources like oil or sourcing them from farmed materials such as wool and cellulose—we unlock the potential for a radically new production paradigm—one that bears more resemblance to growing than to the conventional manufacturing processes. This approach envisions centralizing all components of production into a single material, a single site, and a single process. O° aims to remove the complexity involved in the fabrication of objects by staying within one material class for all technical requirements. Streamlining manufacturing allows us to remove externalities that would incur environmental damage; if we only need one material to make a shoe, we have no need to import specialized components from around the globe. Reducing microplastics, reducing atmospheric greenhouse gasses, and promoting biological growth through targeted biodegra-dation follow as further vectors of possible positive environmental impact. 

Unmatched Versatility: Efficiency in Design, in Tune with Nature
The versatility and automation built into the O° platform enable rapid iterations and an accelerated development process from design to production, enabling a wide array of mechanical, thermal, chemical, and manufacturing properties that meet a broad range of processing needs and applications. Such high levels of versatility, achieved through design tunability across design stages and media—production, processability, and programmable decomposition— are at the core of O°’s designs and platform technology.

Key Features:

Origins: PHAs are derived from naturally-occurring “feedstocks” which include carbon dioxide, methane, sugars, and waste streams. There is a broadening scientific consensus that PHAs can be produced in bulk from atmospheric carbon and other sources that provide it with a very small or even negative carbon footprint.Processability: Considered the most versatile bacterially-derived thermo-polymer class, PHAs are easily integrated into most industrial manufacturing processes, including melt extrusion, injection molding, melt blowing, fiber spinning, and casting.Functionality: With over 13 formulations designed to provide a range of mechan-ical properties for specific uses, our PHA yarn is 6x as flexible as polyester and as soft as lyocell. In place of assembling independently produced parts, each with its homogeneous material properties, we harvest biological mono-materials with highly tunable properties to create gradients of functionality.Product features (pigmentation, scents, branding): The bacterial production of PHAs enable genetically and chemically-encoded pigmentation, scents, and labeling. The genetic label of O° is synthesized in DNA. Once embedded, this label can be used to detect and read the genetic code following polymer biodegradation. This can enable a future where precise identification of disposal and biodegradation products is an everyday reality.

1 https://www.worldfootwear.com/news/10-countries-were-responsible-for-88-of-total-footwear-production-/9148.html
2 https://www.washingtonpost.com/climate-solutions/2024/04/01/plant-based-sole-sneaker/
3 Bodoga, A., Nistorac, A., Loghin, M.C. and Isopescu, D.N., 2024. Environmental Impact of Footwear Using Life Cycle Assessment—Case Study of Professional Footwear. Sustainability, 16(14), p.6094.
4 Lippa, N.M., Krzeminski, D.E., Piland, S.G., Rawlins, J.W. and Gould, T.E., 2017. Biofidelic mechanical ageing of ethylene vinyl acetate running footwear midsole foam. Proceedings of the Institution of Mechanical Engineers, Part P: Journal of Sports Engineering and Technology, 231(4), pp.287-297.
5 Cheah, L., Ciceri, N.D., Olivetti, E., Matsumura, S., Forterre, D., Roth, R. and Kirchain, R., 2013. Manufacturing-focused emissions reductions in footwear production. Journal of cleaner production, 44, pp.18-29.
https://www.ecocenter.org/our-work/healthy-stuff-lab/reports/wolverine-worldwide-shoes-pfas-results/toxic-pfas-chemicals
https://ourworldindata.org/ghg-emissions-by-sector
8 Bodoga, A., Nistorac, A., Loghin, M.C. and Isopescu, D.N., 2024. Environmental Impact of Footwear Using Life Cycle Assessment—Case Study of Professional Footwear. Sustainability, 16(14), p.6094.

View original content to download multimedia:https://www.prnewswire.com/news-releases/oxman-unveils-the-o-shoe–a-100-biodegradable-shoe-made-without-petrochemicals-producing-zero-microplastics-302293106.html

SOURCE OXMAN

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Gen Announces Board Transitions, Welcomes John Chrystal as Peter Feld Departs

Published

on

By

TEMPE, Ariz. and PRAGUE, May 15, 2025 /PRNewswire/ — Gen Digital Inc. (NASDAQ: GEN), a global leader dedicated to powering Digital Freedom, today announced the departure of Peter Feld from its Board of Directors, following his impactful tenure that began in 2018. With this departure, Gen welcomes John Chrystal, former member of MoneyLion’s Board of Directors, who joins the Gen Board as the Company accelerates its innovation and focus on financial wellness.

Peter Feld has been an extraordinary force behind Gen’s evolution. Joining the board of Symantec in 2018, Peter played an integral role in transforming the Company. His leadership was instrumental in the creation of NortonLifeLock, the subsequent merger with Avast, and the birth of Gen as a global consumer Cyber Safety brand and category leader.

“Peter has been a crucial partner and an invaluable asset to Gen,” said Frank Dangeard, Chair of Gen’s Board of Directors. “His vision and commitment have been central to shaping our strategy and setting the foundation for our growth. His legacy will always remain a part of Gen’s DNA as we look toward a future of empowering every individual to live their digital life confidently and securely. On behalf of the entire team, I want to extend my deepest gratitude to Peter for his contributions.”

Peter Feld said, “After serving for six years, it is time for me to step down from the Board. It has been an incredible journey, and I am thankful to Vincent, the entire management team, and the Board of Directors for their commitment to Gen and hard work towards delivering results and value creation. Gen is extremely well-positioned for the future with a strong foundation and exciting new growth prospects through its evolution into financial wellness. I look forward to watching the company continue to thrive.”

Gen also introduces John Chrystal to its Board of Directors. With extensive expertise in fintech and financial innovation, John’s leadership comes at a pivotal time following Gen’s acquisition of MoneyLion, where he served as Chair of the Board of Directors. His appointment signals Gen’s deepening commitment to expanding its portfolio in financial wellness, enabling consumers to safeguard both their digital lives and their financial future. John’s experience will directly contribute to Gen’s renewed mission, extending beyond Cyber Safety, to include financial wellbeing.

John Chrystal adds, “I am excited and humbled to join the extraordinary management and Board team at Gen. I look forward to all the ways I can contribute to the company as it pursues its important mission. In today’s world, trust-based solutions for digital and financial wellness are incredibly important. I look forward to aiding consumers as they strive to make the best financial choices possible, all while safeguarding their financial and digital future.” 

With these transitions, Gen stands at the forefront of industry innovation, laser-focused on delivering unparalleled value to consumers across its family of trusted brands.

About Gen 
Gen (NASDAQ: GEN) is a global company dedicated to powering Digital Freedom through its trusted consumer brands including Norton, Avast, LifeLock, MoneyLion and more. The Gen family of consumer brands is rooted in providing financial empowerment and cyber safety for the first digital generations. Today, Gen empowers people to live their digital lives safely, privately and confidently for generations to come. Gen brings award-winning products and services in cybersecurity, online privacy, identity protection and financial wellness to nearly 500 million users in more than 150 countries. Learn more at GenDigital.com. 

CONTACTS

Investor Contact

Jason Starr

Media Contact

Jess Monney

Gen

Gen

IR@GenDigital.com

Press@GenDigital.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/gen-announces-board-transitions-welcomes-john-chrystal-as-peter-feld-departs-302457250.html

SOURCE Gen Digital Inc.

Continue Reading

Technology

Light AI Reports Financial Results for Q1 2025

Published

on

By

VANCOUVER, BC, May 15, 2025 /CNW/ – Light AI Inc. (“Light AI” or the “Company”) (CBOE CA: ALGO) (FSE: 0HC) (OTCQB: OHCFF), a healthcare technology company focused on developing artificial intelligence (“AI”) health diagnostic and wellness solutions, today announced its financial and operating results for its first quarter of 2025 representing the three months ended March 31, 2025.   Financial information is reported in Canadian dollars (“$”) unless otherwise stated and in accordance with International Financial Reporting Standards (“IFRS”).

Financial and Operating Results Summary for Q1 2025

The Company is currently in the development stage of its software technology offering which is anticipated to be completed with related commercialization commencing in Q3 2025. During the three months ended March 31, 2025, the Company had total operating expenses, exclusive of interest, depreciation and share based payments, of approximately $4.2 million compared to approximately $1.4 million in the three months ended March 31, 2024 with the increase primarily attributable to the Company’s continued investment in product development with total research and development expenses of approximately $1.2 million in Q1 2025 compared to approximately $919,000 in the prior year period in addition to marketing and investor relations activities.

The Company had cash of $11.9 million as of March 31, 2025 compared to $15.2 million as of December 31, 2025.  On January 8, 2025, the Company closed the second of two tranches of the Offering by issuing 2,757,000 units of the Company at $0.55 per unit for aggregate gross proceeds of $1,516,350. The Company had Adjusted Working Capital of $12.6 million as of March 31, 2025 compared to $14.6 million as of December 31, 2025.

“Light AI has made strong progress throughout the first quarter of 2025, inclusive of going public with the completion of related equity financings totaling $18.5 million and strengthening our leadership team with the appointments of Anthony Schaller as President and CTO, John Tse as VP Commercial Development and George Reznik as CFO,” stated Peter Whitehead, CEO of Light AI. “We are committed to commercializing the Company’s AI oriented health and wellness software application in Q3 2025 to address various medical conditions including Strep A, COVID19 and Conjunctivitis (pink eye) to capitalize on our sizable market opportunity leveraging Light AI’s first mover advantage with our innovative, patented and disruptive technology.”

Financial Statements and Management Discussion & Analysis

Please see the Company’s consolidated financial statements (“Financial Statements”) and related Management’s Discussion & Analysis (“MD&A”) for more details. The Financial Statements for the three months ended March 31, 2025, and related MD&A have been reviewed and approved by the Company’s Audit Committee and Board of Directors. For a more detailed explanation and analysis, please refer to the MD&A that has been filed on SEDAR+ at www.sedarplus.ca and is also available on the Company’s website at www.light.ai.

Non-IFRS and Other Financial Measures 

This press release refers to the following non-IFRS measures:

“Adjusted Working Capital” is comprised as current assets less current liabilities. Management believes Adjusted Working Capital is a useful indicator for investors, and is used by management, for evaluating the operating liquidity to the Company. See “Adjusted Working Capital Reconciliation” for a quantitative reconciliation of Adjusted Working Capital to the most directly comparable financial measure.

Such non-IFRS measures and non-IFRS ratio do not have a standardized meaning under IFRS and may not be comparable to a similar measure disclosed by other issuers.

Adjusted Working Capital Reconciliation

                                                                                                        March 31, 2025                  December 31, 2024
                Current Assets                                                                   $14,970,514                        $17,126,245
                Less: Current Liabilities                                                    (   2,352,273)                       (   2,481,677)
                Adjusted Working Capital                                                  $12,618,241                         $14,644,568

About Light AI Inc. (CBOE CA: ALGO / FSE: 0HC / OTCQB: OHCFF)

Light AI Inc. is a technology company focused on developing artificial intelligence health diagnostic solutions. Light AI is developing a technology platform which represents the next generation of patient management: it applies AI algorithms to smartphone images—starting with images of Strep A and anticipated expansion with COVID19 along with other medical conditions —to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind—its hardware platform is the 4.5 billion smartphones that exist in the world today. Light AI is at the forefront of developing innovative diagnostic solutions aimed at improving healthcare delivery worldwide. Their cutting-edge AI powered technology offers rapid, accurate, and cost-effective diagnostic tools designed to address critical healthcare challenges.

In pre-FDA validation studies, Light AI’s algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A Streptococcus (GAS). The algorithm achieved a 96.57% accuracy rate and attained a Negative Predictive Value of 100%, indicating its high reliability in confirming the absence of Streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as Rheumatic Heart Disease (RHD), which imposes a global economic burden exceeding $1 trillion annually. Light AI’s technology offers a significant advancement in the accurate and timely diagnosis of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI’s approach to applying AI to smartphone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin. Light AI’s vision is to combine the smartphone with AI in-the-Cloud to create a Digital Clinical Lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes. Light AI’s commercial launch of its consumer-facing Wellness App initial offering is anticipated to be available in North America in Q3 2025.

ON BEHALF OF THE COMPANY

“George Reznik”
George Reznik
Chief Financial Officer
Telephone: 604-307-6800
Email: greznik@light.ai

For more information, please contact the Company at investors@light.ai or visit https://light.ai/.

Website: https://light.ai/
LinkedIn: LinkedIn/company/Light AI
X (Formerly Twitter): @lightaihealth

Forward-Looking Information:

This news release includes information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, including, but not limited to, the Company’s research and development and commercialization initiatives, the anticipated inflection of the business, the Company’s financial and operational performance and outlook and other statements that contain words such as “believe,” “expect,” “project,” “should,” “seek,” “anticipate,” “will,” “intend,” “positioned,” “risk,” “plan,” “may,” “estimate” or, in each case, their negative and words of similar meaning. By its nature, forward-looking information involves a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking information. These risks, uncertainties and assumptions could adversely affect the outcome of the plans and events described herein. Readers should not place undue reliance on forward-looking information, which is based on the information available as of the date of this news release.  For a list of the factors that may affect any of the Company’s forward-looking statements, please refer to the Company’s annual information form dated April 14, 2025 and other filings made by the Company with the Canadian securities regulatory authorities (which may be viewed under its SEDAR+ profile at www.sedarplus.ca). Light AI disclaims any intention or obligation to update or revise any forward-looking information contained in this news release, whether as a result of new information, future events or otherwise, unless required by applicable law. The forward-looking information included in this news release is expressly qualified in its entirety by this cautionary statement.

SOURCE Light AI Inc.

Continue Reading

Technology

MindHYVE.ai™ and Alkhidmat Foundation Partner to Launch Pakistan’s First Multi-Sector AI Initiative for Social Good

Published

on

By

PESHAWAR, Pakistan, May 15, 2025 /PRNewswire/ — In a transformative move set to redefine humanitarian operations in Pakistan, MindHYVE.ai™, a U.S.-based artificial intelligence company, has signed a landmark Memorandum of Understanding (MoU) with Alkhidmat Foundation Khyber Pakhtunkhwa, one of the nation’s most respected non-profit organizations. The MoU was signed by Belal Faruki, Founder & CEO of MindHYVE.ai™ and Khalid Waqas, President of Alkhidmat Foundation KPK.

This partnership aims to deploy MindHYVE.ai™’s agentic AI systems—starting with the Ava-Education™ large reasoning model and its ArthurAI™ e-learning platform to scale impact across education, healthcare, orphan care, disaster relief, and microfinance initiatives.

As part of the agreement, MindHYVE.ai™ and Alkhidmat will co-establish a Multi-Sector AI Innovation Lab in Peshawar, envisioned as a regional hub for applied AGI (Artificial General Intelligence) solutions in social development. The lab will serve as a launchpad for localized AI training, agent deployment, and academic research, while incubating youth-led startups in partnership with universities and the Khyber Pakhtunkhwa IT Board.

“This isn’t just a tech deployment—this is about building capacity, equity, and long-term national infrastructure for AI-powered social progress,” said Belal Faruki “Alkhidmat’s mission and reach make them the ideal partner for this new frontier in purpose-driven technology.”

Under the first phase, MindHYVE.ai™’s educational agent ArthurAI will be deployed within Alkhidmat’s Bano Qabil program, supporting over 85,000 registered students through adaptive learning paths, multilingual content, and real-time feedback. Subsequent phases will see agents like Chiron (healthcare), Eli (finance), and Carter (retail & e-commerce) integrated into Alkhidmat’s broader humanitarian services.

Alkhidmat KPK President Khalid Waqas commented, “By combining our grassroots infrastructure with MindHYVE.ai™’s AI expertise, we are opening doors for inclusive education, smarter healthcare, and data-informed governance—especially in Pakistan’s most underserved regions.”

MindHYVE.ai™ will provide hosted AI platforms, APIs, training, and agent customization. The collaboration will operate under a non-profit licensing model, with both parties committed to sustainability, ethical governance, and regional language accessibility including Urdu and Pashto.

This MoU signals a powerful step toward AI-for-good innovation in Pakistan and sets a precedent for global public-private humanitarian alliances.

About MindHYVE.ai™
Headquartered in Newport Beach, California, MindHYVE.ai™ builds domain-specific AGI agents, autonomous and semi-autonomous agentic systems and domain specific large reasoning models to transform national infrastructure and industry through intelligent automation and decision systems.

Website: www.mindhyve.ai | Email: hello@mindhyve.ai | Contact: +1 (949) 200-8668

Media Contact
Marc Ortiz
Email: marc.ortiz@mindhyve.ai

Logo – https://mma.prnewswire.com/media/2686713/MindHYVEai.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/mindhyveai-and-alkhidmat-foundation-partner-to-launch-pakistans-first-multi-sector-ai-initiative-for-social-good-302457266.html

Continue Reading

Trending